Literature DB >> 30513495

Localized pancreatic Castleman disease presenting with extrahepatic dilatation of bile ducts: A case report and review of published cases.

Edson Gonçalves Ferreira Junior1, Philippos Apolinario Costa2, Larissa Melo Freire Golveia Silveira3, Rafael Valois Vieira4, Hugo Alessi Lima Martins Soares5, Bruna Menon Loureiro6, Nayane Carolina Pertile Salvioni7, Jose Roberto Coelho Ferreira Rocha8.   

Abstract

INTRODUCTION: Castleman disease (CD) is a rare polyclonal lymphoproliferative disorder of unknown etiology, which usually develops in the mediastinum. It can also occur in the cervical, retroperitoneal and axillary regions. Localized pancreatic CD is quite rare [1]. PRESENTATION OF CASE: The authors herein present a case of a 34 years old female that was diagnosed during a symptomatic cholelithiasis evaluation. During the evaluation, an abdominal ultrasonography revealed a tumor at the head of the pancreas, which went on to generate a dilatation of the extrahepatic bile ducts. This finding was confirmed by abdominal magnetic resonance imaging (MRI). Subsequently, the patient underwent a laparotomy, where a capsulated tumor was found at the head of the pancreas with well-defined margins. The decision was made for tumor excision. The histopathology and immunohistochemistry established CD, hyaline vascular variation. DISCUSSION: The authors of the present paper also performed a literature review concerning Pancreatic CD, where there were found only 33 cases until the time of the writing of this paper, and we have subsequently carried out a retrospective analysis of all cases. In a patient with atypical images, there might be a benefit from a preoperative diagnosis of CD, by using immunohistochemistry analysis in an image guided biopsy. Thus, avoiding unnecessary procedures and surgeries.
CONCLUSION: Localized pancreatic CD is a very rare condition with good prognosis, but it can mimic many common diseases, such as gastrointestinal stromal tumor (GIST), pancreatic neuroendocrine tumor or pancreatic adenocarcinoma.
Copyright © 2018 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Case report; Castleman disease; Pancreatic mass

Year:  2018        PMID: 30513495      PMCID: PMC6279997          DOI: 10.1016/j.ijscr.2018.11.006

Source DB:  PubMed          Journal:  Int J Surg Case Rep        ISSN: 2210-2612


Introduction

CD, also known as angiofollicular or giant lymph node hyperplasia, is a rare lymphoproliferative disorder [[2], [3], [4]]. It was first described in 1954 as giant lymph node hyperplasia [5,6]. Initially, CD was reported as an indolent disorder, which was usually confined to a single lymph node group. However, further case reports have gone on to describe a multicentric form of CD that often manifests a more malignant clinical course [2]. There has been no evidence found of any age predominance, as the condition affects children as well as adults, and neither any significant sex predilection has been found [7]. However, younger people are more likely to have the localized form [8]. Older adults and those with HIV infection are more likely to have the multicentric form [9]. Pancreatic localization of CD is very uncommon, with only a few reports in the literature. A list of the most common diagnoses of mass in the pancreas include adenocarcinoma, cystic tumors, and functioning or non-functioning neuroendocrine tumors. Our objective is to present another case of pancreatic CD that mimics a pancreatic malignant neoplasm and to make a review of the topic with a retrospective analysis of all 33 cases published until now, to the best of our knowledge. This work was reported in line with the SCARE criteria [10].

Presentation of case

A 34 years old female presented herself to our service with a 3-year intermittent abdominal pain, associated with postprandial nausea and vomit. There was no history of fever, night sweats, decreased appetite, weight loss or bowel habit alterations. Family history was non-contributory. The physical examination was unremarkable. Due to the possibility of cholelithiasis, an abdominal ultrasonography (US) was ordered. Abdominal US revealed a retroperitoneal tumor at the head of pancreas, biliary tract dilatation and cholelithiasis. An abdominal magnetic resonance was ordered and showed an isointense smoothly marginated 4 cm mass in T1 (Fig. 1) and a signal intensity similar to the normal in T2 (Fig. 2). Homogenous enhancement, similar to the pancreas in T1 with contrast (Fig. 3). Cholelithiasis and common bile duct dilatation without Wirsung duct disturbance.
Fig. 1

MRI axial T1 without contrast. The arrow points to the isointense 4 cm marginated mass in the pancreas head.

Fig. 2

MRI axial T2. The arrow points to the mass with a signal intensity that is similar to the nomal pancreatic tissue.

Fig. 3

Intraoperative aspect. White arrow: Castleman tumor. Blue arrow: Pancreatic head. Green Arrow: Duodenum.

MRI axial T1 without contrast. The arrow points to the isointense 4 cm marginated mass in the pancreas head. MRI axial T2. The arrow points to the mass with a signal intensity that is similar to the nomal pancreatic tissue. Intraoperative aspect. White arrow: Castleman tumor. Blue arrow: Pancreatic head. Green Arrow: Duodenum. Based on the unspecific radiological findings and epidemiology, a provisional diagnosis of pancreatic adenocarcinoma, gastrointestinal stromal tumor (GIST) or pancreatic neuroendocrine tumor was made. Adenocarcinoma was not the likely cause, as no consumptive symptoms were reported, and usually a pancreatic adenocarcinoma in T1 window with contrast as a hypointense mass rather than a normal pancreatic parenchyma. Neither GIST showed signs of a strong diagnosis. Since it would appear as low signal intensity solid component in T1 and high signal intensity solid component in T2. Pancreatic neuroendocrine tumor is usually hypointense relative to the pancreas in T1 and hyperintense relative to the pancreas in T2, but there is a range of signal intensities. Therefore, a pancreatic neuroendocrine tumor became our principal hypothesis. The fact that the patient had a head pancreatic tumor with bile duct dilatation, associated with symptomatic cholelithiasis led to our preference for a surgical resection. Thus, a pancreatoduodenectomy was performed. On exploration, we found an encapsulated mass bulging in the retroperitoneum at the pancreatic head (Fig. 3). There was also found a gallbladder with cholelithiasis, however, the liver, stomach and other organs appeared to be normal. Based on the macroscopic aspect of the tumor, we opted for excision. The mass was completely excised, while preserving its capsule (Fig. 4), a feature that would not be typical in an pancreatic malignancy. Cholecystectomy was also performed without complications. No surgical approach in the bile duct or endoscopic retrograde cholangiopancreatography was made, since we understood that the dilation was due to extrinsic compression. The patient was discharged during the first postoperative day.
Fig. 4

Macroscopic appearance. The tumor had smooth borders and was capsulated.

Macroscopic appearance. The tumor had smooth borders and was capsulated. An anatomopathological examination showed chronic inflammation in the gallbladder and lymphoid proliferation in the excised tumor. Without immunohistochemistry, the lymphoid proliferation main possible diagnosis was a low grade B cells lymphoma or CD. Immunohistochemistry demonstrated a prominent vascular proliferation and hyalinization of the vessel walls with an onion skin appearance and normal B and T lymphocytes distribution. CD20, CD3, CD10 and KI 67 were positive. BCL1 and BCL2 were negative (Fig. 5). Thus, we concluded that the diagnosis was CD, hyaline vascular variation.
Fig. 5

Immunohistochemistry. On the left: Prominent vascular proliferation and hyalinization of the vessel walls. On the right: Negative BCL2.

Immunohistochemistry. On the left: Prominent vascular proliferation and hyalinization of the vessel walls. On the right: Negative BCL2. The patient was seen on follow-up one month after the surgery. At that time, the patient was asymptomatic. The patient remained asymptomatic during all subsequent follow-ups.

Discussion

Little is known about the cause of this disorder of unknown origin [11]. The etiology and consequently the physiopathology of CD is not clearly known and actually most theories point to different etiological factors depending on the form that the disease presents, either the localized, unicentric or the multicentric form [12]. Seventy percent of cases present in the mediastinum and 20% occur in the axillary, cervical, inguinal and vulvar regions, while approximately 12% occur in the abdomen; mostly located in the pelvis, mesentery and perinephric regions [10]. Extrathoracic localizations are however reported with increasing frequency [2]. In the beginning, CD was classified histologically as two histopathological variants: hyaline vascular, (characterized by small hyaline-vascular follicles and interfollicular capillary proliferation), and plasma cell, (which is characterized by large follicles with intervening sheets of plasma cells) [[13], [14], [15]]. A mixed type of plasma cell and hyaline vascular type was further reported [7], however, rarely seen. Clinically it can be classified as two types: localized and multicentric. The localized form is defined as a single, benign lesion, usually affecting young people [2]. Patients with multicentric disease, either hyaline‐vascular or plasma cell type, do not benefit from surgical management and should be candidates for multimodality therapy [16]. We only found one case of elevation of tumor markers in pancreatic CD. These results changed to normal 7 days after a pancreatic head mass excision. A possible explanation given by the author for the rise and fall of CA 19.9 could be intermittent compression of pancreatic ducts by the mass [17]. However, we found only one case that had a documented dilatation of pancreatic duct, and it did not present with a tumor marker elevation [18]. The current case to the best of our knowledge is the only case that demonstrates a biliary duct dilatation in a unicentric CD, documented by an MRI in a hyaline vascularh type, and no signs of tumor marker elevation either. Imaging techniques like ultrasonography, computed tomography (CT) and MRI have been proven to be helpful in diagnosing retroperitoneal tumors. However, they show conflicts in their findings concerning CD, this incongruence is probably due to multiples histological types. Therefore, imaging procedures should be considered for the differential diagnosis of a pancreatic mass [2]. However, the definitive diagnosis was based on the postoperative pathological findings, including CD located in the pancreas that was only confirmed after pathologic study of the surgical specimen [12]. The CD histological diagnostic is based on cell architecture, and therefore requires the study of the entire surgical specimen [15]. The adhesion of the tumor to the surrounding tissue and hypervascularity in the mass are characteristic features of the hyaline vascular type [19,20]. Immunohistochemical stains for ĸ and λ chains, L26, and UCHL-l [11]. Are currently able to define the diagnoses differentiating between low grade B cells lymphoma. Multiple authors all have failed to establish CD as a diagnosis by endosonography controlled fine-needle aspiration biopsy (EUS-FNA) [8,[21], [22], [23]]. In none of these cases, cytological examination of material obtained from the tumor by EUS-FNA suggested adenocarcinoma, when in fact it was a mixed form of multicentric CD [8]. However, one case was successfully reported as a pancreatic CD preoperative diagnosis by EUS-FNA. The authors used flow cytometric analysis and a determined diagnosis. They claimed that occasional morphologic features on cytologic smears and on cell block section made the preoperative diagnoses possible [24]. The collaborators in Rhee et al in 2008 used an endoscopic ultrasonography guided trucut biopsy, but they could not establish a CD diagnosis. They were unable to make a differentiation from a low grade B-cell lymphoma [25], based only on the anatomopathological. Therefore, the association of the immunohistochemistry with trucut biopsy may be useful as preoperative diagnosis option. Although there are no randomized studies, most published series agree that surgical complete resection is the best therapeutic option for the localized, unicentric form of CD including the plasma cell variant and mixed, with favorable long-term prognosis reports and no cases of malignant transformation [Table 1].
Table 1

XXX.

AUTORYEARCOUNTRYSEXAGESYMPTOMSTOPOGRAPHYPANCREATIC DUCT DILATATIONBILE DUCT DILATATIONSURGERYRECURRENCETIPE
LEPKE [26]1982USAWOMAN71INCIDENTALBODYNONOWHIPPLEDEADHV
LE VAN [27]1989EUAWOMAN64INCIDENTALTAILNONODISTALNO FOLOW UPHV
BROUSSAD [4]1992FRANCE?52FEVER, WAIGHT LOSSBODYNONO?NO FOLOW UPHV
INOUE [28]1992JAPANWOMAN50INCIDENTALHEADNONOEXCISIONNO FOLOW UPHV
CHAULIN [29]1993FRANCEWOMAN50FEVER, FATIGUE, WAIGHT LOSSBODY AND TAILNONODISTALNO FOLOW UPMIXED
BAIKOVAS [17]1994AUSTRALIAWOMAN36RIGHT ILIAC FOSSA PAINPERINONOEXCISIONNO FOLOW UPHV
LE BORGNE [30]1999FRANCEMAN54FATIGUE, WEIGHT LOSS AND VAGE ABDOMINAL PAINHEADNONOHEAD11 MONTHSPLASMA
KIM [31]2001KOREA???HEAD??EXCISIONNO FOLOW UPPLASMA
CAMPRA [11]2002ITALYWOMAN27EPIGASTRIC PAIN, ASTHENIAHEADNONOEXCISION36 MONTHSPLASMA
SOLER [32]2003SPAINMAN36INCIDENTALTAILNONODISTAL PANCREATECTOMY1 YEARPLASMA
YILMAZ [2]2004TURKEYWOMAN56FATIGUE, WEIGHT LOSS AND VAGE ABDOMINAL PAINBODYNONOWHIPPLE3 MONTHSHV
ERKAN [3]2004TURKEYWOMAN45EPIGASTRIC PAINPERINONOEXCISION1 YEARPLASMA
GOETZE [21]2005GERMANYMAN53INCIDENTALTAILNONODISTAL PANCREATECTOMY2 YEARSHV
SU [33]2005TAIWANWOMAN38abdominal fullnessNEEKNONOEXCISION2 YEARSHV
WASIELICA-BERGER [8]2007POLANDMAN54GASTRIC FULLNESS, EPIGASTRIC PAIN, ADYNAMIA, ASTHENIA WEIGHT LOSSMULTICENTRICNONOEXCISED BIOPSIEDDEADMIXED
MAITHEL [34]2007USAMAN76GASTRIC FULLNESS, JAUNDICE, ADYNAMIA, ASTHENIA WEIGHT LOSSMULTICENTRICNOYESEXCISED BIOPSIED6 MONTHSPLASMA
MANGINI [35]2007ITALYWOMAN49INCIDENTALBODYNONOEXCISIONNO FOLOW UPHV
WANG [22]2007USAMAN58INCIDENTALHEADNONOWHIPPLENO FOLOW UPHV
TUNRU-DINH [36]2007EUAWOMAN23ABDOMINAL PAINTAILNON0DISTAL PANCREATECTOMY1 YEARHV
TALARICO [23]2008ROMEMAN69HIPOCONDRYAL PAIN AND FEVERBODYNONO?1 YEARMIXED
RHEE [25]2008JAPANWOMAN50INCIDENTALPERINONOEXCISIONNO FOLOW UPHV
CHARALABOPOULOS [1]2010GREECWOMAN31GASTRIC FULLNESS, EPIGASTRIC PAINPERINONODISTAL PANCREATECTOMY2 YEARSPLASMA
KHASHAB [24]2011USAWOMAN27INCIDENTALBODYNONOEXCISIONNO FOLOW UPHV
FU [9]2012INDIAMAN49INCIDENTALTAILNONODISTAL PANCREATECTOMY1O MONTHHV
2012INDIAMAN39ABDOMINAL PAINHEADNONOEXCISIONNO FOLOW UPHV
2012INDIAMAN74INCIDENTALHEADNONOEXCISION26 MONTHSPLASMA
APODACA-TORREZ [12]2012BRAZILMAN64ADYNAMIA, ASTHENIA WEIGHT LOSSBODYNONOEXCISIONNO FOLOW UPHV
CECKA [15]2013CZECH REPUBLICWOMAN48EPIGASTRICAL PAINTAILNONODISTAL PANCREATECTOMY LAPAROSCOPIC1 YEARHV
MATSUMOTO [18]2015JAPANMAN74INCIDENTALHEADYESNOWHIPPLE2 MONTHSHV
ABDESSAYED [37]2017TUNISIAWOMAN34ABDOMINAL PAINBODYNONOEXCISION?HV
CHENG [38]2018CHINAWOMAN48INCIDENTALBODYNONOEXCISION30 MONTHSHV
2018CHINAWOMAN57TIREDNESS AND FEVERTAILNONOEXCISION?HV
JAIN [39]2012INDIAMAN46LEFT UPPER QUADRANT ABDOMINAL PAINTAILNONOEXCISION12 MONTHHV
CURRENT CASE2017BRAZILWOMAN34ABDOMINAL PAINHEADNOYESEXCISION1 YEARHV
XXX. Only one case of death during treatment and follow-up was reported in all localized pancreatic CD cases. However, this was attributed to comorbid, once the diagnoses were made in intraoperative in light of a different pathology, and the elderly patient died due to postoperative complications [26].

Conclusion

CD affecting the pancreas is a very rare occurrence, even nowadays with a great complementary arsenal for performing a diagnosis. Therefore, this is one of the reasons that CD is not usually included in the list of possible diagnosis. However, pancreatic CD should be taken into consideration in the differential diagnosis of a pancreatic mass. These patients have a good prognosis in a majority of cases unlike malignant tumors. Accordingly, the possibility of a preoperative diagnosis in a patient with atypical findings in MRI or CT by image-guided biopsy associated with immunohistochemistry analysis would improve outcomes by avoiding useless tests, possible neoadjuvant chemotherapy, and finally would reduce surgical procedure morbidity. However, the definitive diagnosis will be performed based on the postoperative pathological findings.

Conflicts of interest

None.

Funding

Authors did not receive any funding for this work.

Ethical approval

We do not require ethical approval to write a case report paper.

Consent

Written informed consent was obtained from the patient for publication of this case report and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal on request.

Author contribution

Edson Gonçalves Ferreira Junior: Conceptualization, Methodology, Resources, Writing the paper, Writing – Review & Editing, Project Administration, Final approval Philippos Apolinario Costa: Conceptualization, Methodology, Data collection, Data analysis/interpretation, Writing – Review & Editing, Final approval Larissa de Melo Freire Gouveia Silveira: Conceptualization, Methodology, Data collection, Resources, Writing – Review & Editing, Final approval Rafael Valois Vieira: Conceptualization, Methodology, Investigation, Writing – Review & Editing, Data collection, Resources, Final approval Hugo Alessi L M Soares: Conceptualization, Methodology, Data collection, Writing – Review & Editing, Supervision, Final approval Bruna Menon Loureiro: Conceptualization, Methodology, Data collection, Resources, Writing – Review & Editing, Final approval Nayane Carolina Pertile Salvioni: Conceptualization, Methodology, Data collection, Resources, Writing – Review & Editing, Final approval Jose Roberto Coelho Ferreira Rocha: Conceptualization, Methodology, Data collection, Resources, Writing – Review & Editing, Final approval

Registration of research studies

Case reports don’t need to be registered.

Guarantor

Edson Gonçalves Ferreira Junior.

Provenance and peer reviewed

Not commissioned, externally peer reviewed.
  37 in total

1.  Castleman disease imitating pancreatic tumor presenting with pericardial and pleural effusion.

Authors:  Justyna Wasielica-Berger; Magdalena Kaniewska; Dariusz Cepowicz; Urszula Wereszczynska-Siemiatkowska; Boguslaw Kedra; Andrzej Dabrowski
Journal:  Pancreas       Date:  2007-11       Impact factor: 3.327

Review 2.  The management of unicentric and multicentric Castleman's disease: a report of 16 cases and a review of the literature.

Authors:  W B Bowne; J J Lewis; D A Filippa; R Niesvizky; A D Brooks; M E Burt; M F Brennan
Journal:  Cancer       Date:  1999-02-01       Impact factor: 6.860

3.  Parapancreatic Castleman disease: contrast-enhanced sonography and CT features.

Authors:  Monica Mangini; Luca Aiani; Elena Bertolotti; Andrea Imperatori; Nicola Rotolo; Antonio Paddeu; Silvia Uccella; Gianpaolo Carrafiello; Carlo Fugazzola
Journal:  J Clin Ultrasound       Date:  2007-05       Impact factor: 0.910

4.  Mediastinal lymph node hyperplasia. Report of a case with growth over an eight year period.

Authors:  W Stanford; R Givler; M S Lawrence
Journal:  J Thorac Cardiovasc Surg       Date:  1966-08       Impact factor: 5.209

5.  Pancreatic Castleman disease treated with laparoscopic distal pancreatectomy.

Authors:  Filip Cecka; Alexander Ferko; Bohumil Jon; Zdenek Subrt; Petra Kasparova; Rudolf Repak
Journal:  Hepatobiliary Pancreat Dis Int       Date:  2013-06

6.  Unicentric Castleman's disease of the pancreas with massive central calcification.

Authors:  Oliver Goetze; Matthias Banasch; Klaus Junker; Wolfgang E Schmidt; Christian Szymanski
Journal:  World J Gastroenterol       Date:  2005-11-14       Impact factor: 5.742

Review 7.  Pancreatic Castleman's Disease: Studies of Three Cases And A Cumulative Review of the Literature.

Authors:  L Fu; X L Wang; S R Babu; Y Zhang; A P Su; Z L Wang; T Hu; B L Tian
Journal:  Indian J Surg       Date:  2012-04-19       Impact factor: 0.656

8.  Rare case of Castleman disease involving the pancreas.

Authors:  Vonny W Tunru-Dinh; Abdul Ghani; Yuel D Tom
Journal:  Am Surg       Date:  2007-12       Impact factor: 0.688

9.  Retroperitoneal unicentric Castleman's disease: A case report.

Authors:  Nihed Abdessayed; Ahlem Bdioui; Houssem Ammar; Rahul Gupta; Nozha Mhamdi; Marwa Guerfela; Moncef Mokni
Journal:  Int J Surg Case Rep       Date:  2017-01-05

Review 10.  Castleman's disease in the head of the pancreas: report of a rare clinical entity and current perspective on diagnosis, treatment, and outcome.

Authors:  Hongbei Wang; Rosemary L Wieczorek; Michael E Zenilman; Fidelina Desoto-Lapaix; Bimal C Ghosh; Wilbur B Bowne
Journal:  World J Surg Oncol       Date:  2007-11-20       Impact factor: 2.754

View more
  1 in total

1.  Ultrasound and radiological features of abdominal unicentric castleman's disease: A case series study.

Authors:  Kun Lv; Yanan Zhao; Wen Xu; Chao Zhang; Pintong Huang
Journal:  Medicine (Baltimore)       Date:  2020-05       Impact factor: 1.817

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.